Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. - Wikidata - wikimedia - TriplyDB

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

http://www.wikidata.org/entity/Q35922727

about

Metabolism of kidney cancer: from the lab to clinical practice Clinical relevance of circulating cell-free microRNAs in ovarian cancer Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review Diagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-Analysis Extracellular microRNAs in urologic malignancies: chances and challenges Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort The complete exosome workflow solution: from isolation to characterization of RNA cargo Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial.Minireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases.Expression of serum microRNA-378 and its clinical significance in renal cell carcinoma.Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosis Noninvasive micromarkers The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research Circulating miRNAs as new blood-based biomarkers for solid cancers.Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers Renal cancer biomarkers: the promise of personalized care Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer miRNAs can be generally associated with human pathologies as exemplified for miR-144.Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.Regulation of cancer metastasis by cell-free miRNAs.MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer.Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.MicroRNAs in urine are not biomarkers of multiple myeloma Prenatal ethanol exposure alters adult hippocampal VGLUT2 expression with concomitant changes in promoter DNA methylation, H3K4 trimethylation and miR-467b-5p levels The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.The regulation and function of microRNAs in kidney diseases.MiRNAs which target CD3 subunits could be potential biomarkers for cancers.MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis.MicroRNA-300 inhibited glioblastoma progression through ROCK1.

P2860

Q24600512-06511523-BC95-4B01-BFE4-58561C9F0F15 Q26747154-CFC47D5C-D4CA-4555-9DEB-490922C717B5 Q26752925-1D2EE014-C3B3-4AF2-AB41-589975D5D74A Q26770132-DF0E36C4-440F-4726-A6E5-30CE69E71F05 Q26774431-E9630080-F22E-4FB1-9079-EDD961C646AC Q26785539-33F187D6-700E-49B1-B3F7-0B85E431B472 Q26786185-96EC3DDD-644C-42D1-9421-FF8395666F2F Q26866043-49A3D51C-2644-401C-A823-C3F9740D5542 Q27332302-63B1389C-1747-4007-9D1D-1A0CA43B76CF Q28546311-032C152B-CA04-431B-ADFD-09F3E606A016 Q28662332-CF5751E1-904A-44FA-B71D-57964484E205 Q33439523-915421C9-8FDE-4909-9CEA-65A6047AEB10 Q33635886-EF08015E-B884-4467-AC9F-F967BC63A882 Q33846732-11F04347-02B3-4E42-B897-199166EEB237 Q34029232-64291570-DCE7-4EE6-BE29-78BF3C3A5C1C Q34089884-10C59B52-9643-4F30-9DEB-7F89244F6C4A Q34111606-89E79F01-73CE-450A-8B9D-411C180A546A Q34252557-2D23B33B-7399-44E9-A134-9E189C29C8D6 Q34331651-E3794F52-AE06-4814-B8AC-4ACD2E655231 Q34357952-514A128F-64C2-4986-9BF4-EAE8088C90E1 Q34422845-1A3882C9-6214-4AE1-9C0F-96CC39D53426 Q34614989-BEFB2D44-B28C-4C44-94CE-FBC997D07A42 Q34720619-877B5893-C4DA-4F1D-96D0-1EC4F6DBD32E Q34989110-BF6B5B74-94AB-425D-A454-86772B38839B Q35034340-0EB29948-4D21-47C9-B11A-7DA6C6EE4418 Q35099041-10C4B07B-E8BE-4787-BFA4-1C3DFB3B9510 Q35211371-987D75FD-2154-485D-88FA-977DC02696E3 Q35606229-82BBC7CD-6196-435A-BD93-0BAE8FFBB655 Q35650689-5DE8A126-1A95-4000-A7A0-122997D0D651 Q35943345-8F704616-7FDE-4E3D-B318-F4E2917F2B40 Q35968528-7AD20FCC-4E66-4979-9B30-77DDB75DDDAA Q36089046-6F7459F8-FE24-4704-A5F0-90A7EA0BDDB9 Q36105003-CF8E2B45-E398-4EAD-9C46-B83E15416241 Q36106421-B565FB01-0D54-46E5-943E-7FFBD6B86271 Q36247287-B7882F07-8F06-49CB-912B-75FB01614546 Q36902949-F916D293-A3AC-401A-89F1-59761A7C458A Q36960910-EFBB396E-36C2-4B86-B04B-69828D021E4F Q37297742-524BC029-3DD7-42E8-A14E-EAFC8F8AA936 Q37322972-5FAA3E53-B0A6-49A1-84FC-EAA277840210 Q37392761-558F4229-EC96-4531-8017-5770982B2B36

P2860

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

http://www.wikidata.org/entity/Q35922727

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Circulating miR-378 and miR-45 ...... kers for renal cell carcinoma.

@ast

Circulating miR-378 and miR-45 ...... kers for renal cell carcinoma.

@en

type

label

Circulating miR-378 and miR-45 ...... kers for renal cell carcinoma.

@ast

Circulating miR-378 and miR-45 ...... kers for renal cell carcinoma.

@en

prefLabel

Circulating miR-378 and miR-45 ...... kers for renal cell carcinoma.

@ast

Circulating miR-378 and miR-45 ...... kers for renal cell carcinoma.

@en

P1433

Q35922727-AA30579F-D061-44B8-9DF2-E3BB9176CC2C

P1476

Q35922727-9FBAB102-5A39-404A-A702-EAC9D42EF8AD

P2093

Q35922727-0B6C6E3E-4B1B-429B-B1BB-16B5AE8C4A5D

Q35922727-22F3C520-FBEA-476F-BE3B-A42CCB30DDFB

Q35922727-5E21E6EE-DA1B-4911-B485-5A398F2121BA

Q35922727-61AEC684-7B48-442B-AE1F-9EF8A6E27EE1

Q35922727-CBE8D105-D250-46CF-8D97-E6AA5DB714B5

Q35922727-CFB59A23-3052-40E1-8145-E42474951E16

Q35922727-D7EF8F7B-94AD-4618-8C04-7726FD0B9673

Q35922727-FC410AF7-6130-4A62-A18D-525FC2332E1C

P2860

Q35922727-05D75094-65CF-436B-BDBE-27A1524D6399

Q35922727-080AD37D-8EFE-4BDE-86DF-7FF9CD84F51D

Q35922727-1BB47A60-75D3-4D75-A2F5-93064DE484C6

Q35922727-1DC3ADD6-7C05-477F-A62C-6C2A0A024BAF

Q35922727-20C03123-60CD-4D44-B8F9-003DF226189B

Q35922727-2D3C1B24-14F5-439A-AD79-E0BF00173C50

Q35922727-30D0CA05-B247-4E71-89A5-2F7F69F02E5C

Q35922727-3739277E-0DA8-4AD4-B0D5-10FCE415F3A6

Q35922727-3B829238-98F7-4D50-A712-54E6CD1F209F

Q35922727-40750399-ED27-4D50-8463-1EF0F8CCB17E

P2888

Q35922727-E8260196-C5CD-4131-AA63-A27BDCAA4F4D

P304

Q35922727-8FDAE01D-3C9A-476C-A1B2-CA1C601530CC

P31

Q35922727-385643CB-E828-484C-AA17-03E69EF71684

P356

Q35922727-A6CC3FFC-B284-4C07-8B8C-A18C180D9835

P478

Q35922727-39761B84-D7FF-4932-9BAE-8D10B81DAABE

P50

Q35922727-559EFF89-9FA7-4F7B-8904-4A969D7AC458

P577

Q35922727-C659B3B9-F981-490E-866E-5186536FC582

P5875

Q35922727-9016D495-4603-4251-882A-31038E29E179

P6179

Q35922727-A7D9BD86-A4AE-4732-A3EF-7BBBFB7E4A7A

P698

Q35922727-A3A98530-6763-444E-B429-F670494F2B17

P921

Q35922727-FF83DA10-FA67-46F8-93BF-F497FFF749B1

P932

Q35922727-030C6C59-CEBF-4A0E-924C-12F43A3A6CAC

P356

1479-5876-10-55

P1433

Journal of Translational Medicine

P1476

Circulating miR-378 and miR-45 ...... rkers for renal cell carcinoma

@en

P2093

Alexandr Poprach

http://www.w3.org/2001/XMLSchema#string

Lenka Radova

http://www.w3.org/2001/XMLSchema#string

Marek Svoboda

http://www.w3.org/2001/XMLSchema#string

Martina Redova

http://www.w3.org/2001/XMLSchema#string

Ondrej Slaby

http://www.w3.org/2001/XMLSchema#string

Radek Lakomy

http://www.w3.org/2001/XMLSchema#string

Robert Iliev

http://www.w3.org/2001/XMLSchema#string

Rostislav Vyzula

http://www.w3.org/2001/XMLSchema#string

P2860

A microRNA expression signature of human solid tumors defines cancer gene targets

Circulating microRNAs as stable blood-based markers for cancer detection.

Oncomirs - microRNAs with a role in cancer

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.

Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival.

P2888

1479-5876-10-55

P304

55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-10-55

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Jana Nekvindová

P577

2012-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221968848

http://www.w3.org/2001/XMLSchema#string

P6179

1015480248

http://www.w3.org/2001/XMLSchema#string

P698

22440013

http://www.w3.org/2001/XMLSchema#string

P921

P932

3340316

http://www.w3.org/2001/XMLSchema#string